Our findings also align with the observation of lower mean IGF-1 levels in individuals with high Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), suggesting a role for IGF-1 in insulin resistance in patients with Type 2 Diabetes Mellitus. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.